Utility of hematologic and volume, conductivity, and scatter parameters from umbilical cord blood in predicting chorioamnionitis

International Journal of Laboratory Hematology

Volumn 32, Issue 3, 2010, Pages 351-359

  Lee, J C ^a   Ahern, T P ^b   Chaves, F P ^c   Quillen, K ^a  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY   (United States)

^c Surgical Pathology Center Diagnóstika   (Brazil)

Author keywords

Chorioamnionitis; Umbilical cord blood; VCS 4

Indexed keywords

ADULT; ANALYZER; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLOOD CELL COUNT; BLOOD GROUP TYPING; BLOOD VOLUME; CHORIOAMNIONITIS; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; HEMATOLOGICAL PARAMETERS; HEMATOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LEUKOCYTE DIFFERENTIAL COUNT; MAJOR CLINICAL STUDY; MOTHER; NEUTROPHIL COUNT; NEWBORN; NEWBORN SEPSIS; PATHOLOGY; PLACENTA; PRECURSOR; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; UMBILICAL CORD BLOOD; BLOOD EXAMINATION; CELL SIZE; CHEMISTRY; FETUS BLOOD; PREDICTIVE VALUE; PREGNANCY;

ADULT; CELL SIZE; CHORIOAMNIONITIS; FEMALE; FETAL BLOOD; HEMATOLOGIC TESTS; HUMANS; INFANT, NEWBORN; PREDICTIVE VALUE OF TESTS; PREGNANCY;

EID: 77953549271     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2009.01187.x     Document Type: Article

References (24)

1. Ahluwalia J., Tinker A., Clapp L.H., Duchen M.R., Abramov A.Y., Pope S., Nobles M. & Segal A.W. (2004) The large-conductance Ca2+ -activated K2+ channel is essential for innate immunity. Nature 427, 853-858.
2. American College of Gynecology and Obstetrics Committee Opinion No 279 (2002) Prevention of early-onset group B streptococcal disease in newborns. Obstetrics and Gynecology 100, 1405-1412.
3. deAraujo M.C., Schultz R. & Vaz F.A. (1994) A case-control study of histological chorioamnionitis and neonatal infection. Early Human Development 40, 51-58.
4. Arya S., Quillen K., Daniels S. & Chaves F. (2007) Use of the mean neutrophil volume greatly improves the laboratory diagnosis of bacteremia. Modern Pathology 20: 267A (Poster Presentation at USCAP Meeting in San Diego, CA, USA).
5. Center for Disease Control and Prevention (2005) Early-onset and late-onset neonatal group B streptococcal disease -United States, 1996-2004. MMWR. Morbidity and Mortality Weekly Report 54, 1205-1208.
6. Chaves F., Tierno B. & Xu D. (2005) Quantitative determination of neutrophil VCS parameters by the Coulter automated hematology analyzer: new and reliable indicators for acute bacterial infection. American Journal of Clinical Pathology 124, 440-444.
7. Dempsey E., Chen M.F., Kokottis T., Vallerand D. & Usher R. (2005) Outcome of neonates less than 30 weeks gestation with histologic chorioamnionitis. American Journal of Perinatology 22, 155-159.
8. Elimian A., Verma U., Beneck D., Cipriano R., Visintainer P. & Tejani N. (2000) Histologic chorioamnionitis, antenatal steroids, and perinatal outcomes. Obstetrics and Gynecology 96, 333-336.
9. Escobar G.J., Li D.K., Armstrong M.A., Gardner M.N., Folck B.F., Verdi J.E., Xiong B. & Bergen R. (2000) Neonatal sepsis workups in infants ≥ 2000 grams at birth: a population-based study. Pediatrics 106, 256-263.
10. Greenberg D.N. & Yoder B.A. (1990) Changes in the differential white blood cell count in screening for group B streptococcal sepsis. Pediatric Infectious Disease Journal 9, 886-889.
11. Hansen A., Forbes P. & Buck R. (2005) Potential substitution of cord blood for infant blood in the neonatal sepsis evaluation. Biology of the Neonate 88, 12-18.
12. Jackson G.L., Engle W.D., Sendelbach D.M., Vedro DA., Josey S., Vinson J., Bryant C, Hahn G. & Rosenfeld C.R. (2004) Are complete blood cell counts useful in the evaluation of asymptomatic neonates exposed to suspected chorioamnionitis? Pediatrics 113, 1173-1180.
13. Koren G. (1997) Therapeutic drug monitoring principles in the neonate. Clinical Chemistry 43, 222-227.
14. Krause J.R. (1990) Automated differentials in the hematology laboratory. American Journal of Clinical Pathology 93, 11-16.
15. Manucha V., Rusia U., Sikka M., Faridi M. & Madan N. (2002) Utility of haematological parameters and C-reactive protein in the detection of neonatal sepsis. Journal of Paediatrics and Child Health 38, 459-464.
16. Mehta R., Nanjundaswamy S., Shen-Sch-warz S. & Petrova A. (2006) Neonatal morbidity and placental pathology. Indian Journal of Pediatrics 73, 25-28.
17. Nordenvall M. & Sandstedt B. (1990) Chorioamnionitis in relation to gesta-tional outcome in a Swedish population. European Journal of Obstetrics, Gynecology, and Reproductive Biology 36, 59-67.
18. Novak R.W. & Platt M.S. (1985) Significance of placental findings in early-onset group B streptococcal neonatal sepsis. Clinical Pediatrics 24, 256-258.
19. Ogunyemi D., Murillo M., Jackson U., Hunter N. & Alperson B. (2003) The relationship between placental histo-pathology findings and perinatal outcome in preterm infants. The Journal of Maternal-Fetal & Neonatal Medicine 13, 102-109.
20. Richardson-Jones A. (1990) An automated hematology instrument for comprehensive WBC, RBC, and platelet analysis. American Clinical Laboratory 9, 18-22.
21. Rodwell R.L., Leslie A.L. & Tudehope D.I. (1988) Early diagnosis of neonatal sepsis using hematologic scoring system. Journal of Pediatrics 112, 761-767.
22. Schrag S., Gorwitz R., Fultz-Butts K. & Schuchat A. (2002) Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR. Recommendations and Reports 51(RR-11), 1-22.
23. Smulian J.C., Shen-Schwarz S., Vintzileos A.M., Lake M.F. & Ananth C.V. (1999) Clinical chorioamnionitis and histologic placental inflammation. Obstetrics and Gynecology 94, 1000-1005.
24. Zangwill K.M., Schuchat A. & Wenger J.D. (1992) Group B streptococcal disease in the United States, 1990: report from a multi-state active surveillance system. Morbidity and Mortality Weekly Report. Surveillance Summaries 41, 25-32.